What was the market valuation of the North America drug screening market in 2024?

The market valuation was $1200.0 Million in 2024. Read More

What is the projected market valuation for the North America drug screening market by 2035?

The projected valuation for 2035 is $1800.0 Million. Read More

What is the expected CAGR for the North America drug screening market during the forecast period 2025 - 2035?

The expected CAGR is 3.75% during the forecast period 2025 - 2035. Read More

Which segment had the highest valuation in the North America drug screening market in 2024?

In 2024, the 'Urine Testing' segment had the highest valuation at $720.0 Million. Read More

What are the key technologies used in the North America drug screening market?

Key technologies include Immunoassay, Chromatography, Mass Spectrometry, and PCR Testing. Read More

Which end-use segment is projected to grow the most in the North America drug screening market?

The 'Hospitals and Clinics' segment is projected to grow significantly, with a valuation range of $400.0 - $600.0 Million. Read More

What is the valuation range for Multi-Panel tests in the North America drug screening market?

The valuation range for Multi-Panel tests is $600.0 - $900.0 Million. Read More

What is the valuation range for Mass Spectrometry technology in the North America drug screening market?

The valuation range for Mass Spectrometry technology is $400.0 - $600.0 Million. Read More

How does the North America drug screening market compare to other regions?

While specific comparisons are not provided, the North America market is characterized by strong growth and significant investments from leading companies. Read More

North America Drug Screening Market

Q: Who are the leading companies in the North America drug screening market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, and Quest Diagnostics. Read More

ID: MRFR/LS/0978-HCR

50 Pages

Vikita Thakur

Last Updated: April 06, 2026

North America Drug Screening Market - by Test Sample (Urine, Blood, Hair and Saliva) by condition (Unconsciousness, Panic Attack, Chest Pain, Drug Allergies and Others) - Growth & Industry Forecast 2025 To 2035

North America Drug Screening Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)3.75%

2024 Market Size$ 1,200 Million

2025 Market Size$ 1,245 Million

2035 Market Size$ 1,800 Million

Key Players

Thermo Fisher Scientific

Abbott Laboratories

Roche Diagnostics

Siemens Healthineers

Quest Diagnostics

Alere Inc.

Trends

Technological Advancements
Regulatory Compliance
Focus on Preventive Healthcare

Opportunities

Workplace Safety Regulations
Increasing Substance Abuse Rates
Rising Demand for Home Testing Kits

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Chemicals and Materials, BY Type (USD Million) | |
  1. 4.1.1 Urine Testing | |
  2. 4.1.2 Saliva Testing | |
  3. 4.1.3 Blood Testing | |
  4. 4.1.4 Hair Testing |
2. 4.2 Chemicals and Materials, BY Technology (USD Million) | |
  1. 4.2.1 Immunoassay | |
  2. 4.2.2 Chromatography | |
  3. 4.2.3 Mass Spectrometry | |
  4. 4.2.4 PCR Testing |
3. 4.3 Chemicals and Materials, BY End Use (USD Million) | |
  1. 4.3.1 Workplace | |
  2. 4.3.2 Drug Rehabilitation Centers | |
  3. 4.3.3 Hospitals and Clinics | |
  4. 4.3.4 Law Enforcement |
4. 4.4 Chemicals and Materials, BY Panel Size (USD Million) | |
  1. 4.4.1 Single Panel | |
  2. 4.4.2 Multi-Panel | |
  3. 4.4.3 Expanded Panel 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Thermo Fisher Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Abbott Laboratories (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Roche Diagnostics (CH) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Siemens Healthineers (DE) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Quest Diagnostics (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Alere Inc. (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 LabCorp (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Bio-Rad Laboratories (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Medtox Scientific (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS BY TYPE |
6. 6.3 NORTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
7. 6.4 NORTH AMERICA MARKET ANALYSIS BY END USE |
8. 6.5 NORTH AMERICA MARKET ANALYSIS BY PANEL SIZE |
9. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS |
12. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
14. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS |
15. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE) |
16. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million) |
17. 6.14 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE) |
18. 6.15 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
19. 6.16 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE) |
20. 6.17 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million) |
21. 6.18 CHEMICALS AND MATERIALS, BY PANEL SIZE, 2024 (% SHARE) |
22. 6.19 CHEMICALS AND MATERIALS, BY PANEL SIZE, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USE, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PANEL SIZE, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

North America North America Drug Screening Market Segmentation

North America Drug Screening Market By Type (USD Million, 2025-2035)

Urine Testing
Saliva Testing
Blood Testing
Hair Testing

North America Drug Screening Market By Technology (USD Million, 2025-2035)

Immunoassay
Chromatography
Mass Spectrometry
PCR Testing

North America Drug Screening Market By End Use (USD Million, 2025-2035)

Workplace
Drug Rehabilitation Centers
Hospitals and Clinics
Law Enforcement

North America Drug Screening Market By Panel Size (USD Million, 2025-2035)

Single Panel
Multi-Panel
Expanded Panel

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”